Publication Month: Feb 2022 |
Report Code: TIPRE00018821
| No. of Pages:
| Category: Pharmaceuticals
| Status: Published
No. of Pages 183
People may get into several behavioral addictions for various reasons, severely affecting their health and well-being from a long-term perspective. Behavioral rehabilitation is a fiercely used methodology to retrieve patients from behavioral habits. Behavioral addictions are the same as substance misuse addictions. Patients usually need to undergo different methodological courses and medications. Behavioral rehabilitation activities are prescribed for an extended period. Rehabilitation therapy is implemented by professionals who understand specific addictions.
|Market Size Value in||US$ 350.63 Million in 2021|
|Market Size Value by||US$ 540.84 Million by 2028|
|Growth rate||CAGR of 6.4% from 2021 to 2028|
|No. of Pages||183|
|No. of Tables||139|
|No. of Charts & Figures||77|
|Historical data available||Yes|
|Segments covered||Treatment, Application, Healthcare Setting|
|Regional scope||North America; Europe; Asia Pacific; Latin America; MEA|
|Country scope||US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
|Free Sample Copy Available|
An increase in the prevalence of behavioral disorders, easy availability of behavioral rehabilitation therapies, and a rise in the number of product launches are driving the market.
Behavioral disorders are a common issue among children and adolescents across the world. It involves a pattern of disruptive behaviors that last for at least six months, causing problems for them at home, in school, and in other social situations. Disruptive behavioral disorders (DBDs) contribute significantly to the vast array of diseases among children and adolescents. Categorized as psychiatric disorders, DBDs mainly include conduct disorder (CD) and oppositional defiant disorder (ODD).
According to the Center for Disease Control and Prevention (CDC), 5.1% of all US children, aged 4-17 years, have been reported as having severe emotional or behavioral difficulties by their parents. Emotional and behavioral disorders affect 10–15% of children worldwide, the National Institute of Mental Health (NIMH) stated in a recent report. Another common behavioral disorder, obsessive-compulsive disorder (OCD), affects around 2–3% of people in the US. Among adults, the number of affected females is slightly more than males. OCD often begins in childhood, adolescence, or early adulthood; the average age when symptoms appear is 19 years old
Many researches show that addiction and depression are treatable. The National Institute on Drug Abuse (NIDA), which supports more than 85% of the world's research on drug abuse and addiction, has found that counseling therapy services is the most effective treatment approach. Treatments for behavioral disorders mainly focus on behavioral treatment and medication. Parent management training and family therapy are considered quite effective for managing behavioral disorders. Cognitive behavioral therapy treatment has surfaced as the most used mechanism for managing the symptoms of behavioral disorders.
Based on application, the behavioral rehabilitation market is segmented into anxiety disorders, mood disorders, substance abuse disorders, personality disorders, and attention deficit disorders. The anxiety disorders segment held the largest market share in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.
In terms of treatment, the behavioral rehabilitation market is segmented into drugs, and counselling and therapy services. The counselling and therapy service segment held the largest market share in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.
Based on healthcare setting, the behavioral rehabilitation market is segmented into outpatient behavioral rehabilitation, inpatient behavioral rehabilitation, and residential behavioral rehabilitation. The outpatient behavioral rehabilitation segment held the largest market share in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.
Product launches is the most commonly adopted strategy by companies to expand their footprints and product portfolios in the market. Moreover, the companies have implemented various inorganic strategies such as mergers and acquisitions, and partnerships. For instance, in March 2019, the FDA approved Johnson & Johnson Health Care Systems Inc.'s Spravato (esketamine) nasal spray to treat depression in adults.